Sanofi-Aventis U.S. LLC is recalling 51,325 vials of Admelog (insulin lispro injection), 100 units/mL (U-100), in 3mL multi-dose vials. The recall was issued because some vials have a malformed crimped collar seal, which means the sterility of the injectable medication cannot be guaranteed. If you use this medication, you should consult with your doctor or pharmacist to determine if your supply is affected and how to obtain a safe replacement.
A malformed seal may allow bacteria or other contaminants to enter the vial. Injecting a contaminated medication poses a significant risk of serious infection or other medical complications.
You have 2 options:
Recall initiated due to malformed crimped collar seal affecting assurance of sterility.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.